We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Takeda Pharmaceuticals USA Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Published: November 2018
Pages: 18
Code: 09CED970C3D5D18B6B4C2AFA0C929C70
Format: PDF
Publisher GlobalData
From Add to basket
$ 250.00

Additonal Information

  • Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, pioglitazone, pioglitazone and metformin HCl, azilsartan medoxomil, alogliptin, peginesatide, lansoprazole, colchicine, USP, dexlansoprazole, ramelteon and febuxostat. It offers products in therapeutic areas including cardiovascular disease, central nervous system disorders, bone and joint disorders, gastroenterology, gynecology disorders, kidney disorders and other infectious diseases. TPUSA conducts research and development activities to develop new drugs. The company markets products through its distributors in the US. TPUSA is headquartered in Deerfield, Illinois, the US.
  • provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
  • GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Reasons to buy

Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company.
Add to basket
  • Table of Contents
  • Table of Contents 3
  • List of Tables 4
  • List of Figures 4
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deal Details 10
  • Partnerships 10
  • Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 10
  • Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 11
  • Affymax Enters Into Co-Promotion Agreement With Takeda For Peginesatide 12
  • Asset Transactions 13
  • Caraco Pharma Completes Acquisition Of Non-Colcrys Business Of URL Pharma From Takeda Pharma For US$65 Million 13
  • Takeda Pharmaceuticals USA Inc - Key Competitors 14
  • Takeda Pharmaceuticals USA Inc - Key Employees 15
  • Takeda Pharmaceuticals USA Inc - Locations And Subsidiaries 16
  • Head Office 16
  • Recent Developments 17
  • Corporate Communications 17
  • Oct 06, 2017: Takeda Donates $100,000 to Local, Regional Charities as Part of Company’s Takeda Cares Day Event 17
  • Appendix 18
  • Methodology 18
  • About GlobalData 18
  • Contact Us 18
  • Disclaimer 18
  • List of Tables
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Key Facts 2
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
  • Takeda Pharmaceuticals USA Inc, Deals By Therapy Area, 2012 to YTD 2018 8
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
  • Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 10
  • Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 11
  • Affymax Enters Into Co-Promotion Agreement With Takeda For Peginesatide 12
  • Caraco Pharma Completes Acquisition Of Non-Colcrys Business Of URL Pharma From Takeda Pharma For US$65 Million 13
  • Takeda Pharmaceuticals USA Inc, Key Competitors 14
  • Takeda Pharmaceuticals USA Inc, Key Employees 15
  • List of Figures
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
  • Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Keywords
;